scholarly article | Q13442814 |
P2093 | author name string | Ji Chen | |
Liang Wang | |||
Jie Song | |||
Yang Song | |||
Chong Yan | |||
Chun Jin | |||
Jianying Xi | |||
Yongjun Zhu | |||
Zhiming Chen | |||
Chongbo Zhao | |||
Jianyong Ding | |||
P2860 | cites work | edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 |
Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS | Q28143732 | ||
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci | Q28281906 | ||
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator | Q28506619 | ||
Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population | Q74598084 | ||
Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody | Q81817155 | ||
Increased frequency of CCR7+CD4+ T cells from patients with primary Sjögren's syndrome: An indicator of disease activity rather than of damage severity | Q88443079 | ||
The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy | Q89422869 | ||
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 | Q28589743 | ||
limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
14th International Workshop on Ataxia-Telangiectasia ATW2012. | Q30411286 | ||
GeneAnalytics: An Integrative Gene Set Analysis Tool for Next Generation Sequencing, RNAseq and Microarray Data | Q31059199 | ||
Assessing the human immune system through blood transcriptomics | Q33629522 | ||
Thymoma: state of the art. | Q33773352 | ||
Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America | Q33909223 | ||
Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells. | Q34543668 | ||
Ankyrin repeat: a unique motif mediating protein-protein interactions. | Q34592264 | ||
VarElect: the phenotype-based variation prioritizer of the GeneCards Suite | Q36064361 | ||
Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways | Q36318396 | ||
Increased frequency of thymic T follicular helper cells in myasthenia gravis patients with thymoma | Q36724197 | ||
B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity | Q37093281 | ||
Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis | Q37134157 | ||
The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases | Q37382950 | ||
TL1A and DR3, a TNF family ligand‐receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation | Q37438611 | ||
The inhibitory receptor BTLA controls γδ T cell homeostasis and inflammatory responses. | Q37540859 | ||
Adenovirus-Mediated CCR7 and BTLA Overexpression Enhances Immune Tolerance and Migration in Immature Dendritic Cells | Q37723724 | ||
Thymoma and paraneoplastic myasthenia gravis | Q37727991 | ||
Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules | Q38113962 | ||
Thymoma related myasthenia gravis in humans and potential animal models. | Q38363135 | ||
Myasthenia gravis: subgroup classification and therapeutic strategies | Q38588012 | ||
Death receptor 3 mediates necroptotic cell death. | Q38748379 | ||
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55. | Q38770641 | ||
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization | Q42064511 | ||
AAV-sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo | Q42198167 | ||
Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells | Q42211475 | ||
Thymoma-associated myasthenia gravis: On the search for a pathogen signature | Q42242498 | ||
Correction: The TNF-Family Ligand TL1A and Its Receptor DR3 Promote T Cell-Mediated Allergic Immunopathology by Enhancing Differentiation and Pathogenicity of IL-9-Producing T Cells. | Q42353796 | ||
Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients | Q43062426 | ||
An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection | Q47644604 | ||
CCR9 AND CCR7 are overexpressed in CD4- CD8- thymocytes of myasthenia gravis patients | Q51756122 | ||
T Cell Subsets in the Germinal Center: Lessons from the Macaque Model | Q52657148 | ||
Thymoma in Patient with Myasthenia Gravis Has Significantly Fewer Forkhead Box P3 Positive Lymphocytes than that without One. | Q53313660 | ||
CCR7 on CD4+T Cells Plays a Crucial Role in the Induction of Experimental Autoimmune Encephalomyelitis | Q57623401 | ||
Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis | Q58586433 | ||
ATM in breast and brain tumors: a comprehensive review | Q58804970 | ||
CCR7-mediated migration in the thymus controls γδ T-cell development | Q60709836 | ||
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci | Q60896353 | ||
P4510 | describes a project that uses | limma | Q112236343 |
P433 | issue | 6 | |
P921 | main subject | myasthenia gravis | Q8285 |
The Cancer Genome Atlas | Q3979425 | ||
P304 | page(s) | 2315-2323 | |
P577 | publication date | 2019-06-01 | |
P1433 | published in | Journal of thoracic disease | Q26841814 |
P1476 | title | The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells | |
P478 | volume | 11 |
Search more.